Benitec Biopharma announces the appointment of Kishen Mehta to the board of directors of the Company, effective June 26, 2024. Mr. Mehta’s appointment follows the $40M private investment in public equity financing announced on April 18th, led by long-term investor Suvretta Capital, where he serves as portfolio manager.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BNTC:
- Benitec Biopharma initiated with an Overweight at Piper Sandler
- Benitec Biopharma files to sell 32.87M shares of common stock for holders
- Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update
- Benitec Biopharma reports Q3 EPS ($1.64) vs. ($2.67) last year
- Benitec Biopharma (BNTC) Q3 Earnings Cheat Sheet